|
Group II. Scotochromogenic Mycobacterium
(M. scrofulaceum, M. szulgai, M. gordonae)
Read the Chapter
Sliding Table of
Contents on the left of the screen
Tables and Figures
Table 1: Suggested Drugs for Scotochromogenic
Mycobacterial Diseases
Table 2: Recommended Antimycobacterial
Dosages
Vignettes
Guideline: An Official ATS/IDSA
Statement: Diagnosis, Treatment, and Prevention of Nontuberculosis
Mycobacterial Diseases. Am J Respir Crit Care Med 2007:175;367-416.
Deresinski S
et al.
Natural History of Lymphadenitis due to Nontuberculous
Mycobacteria (NTM).
Clin Infect Dis. 2009 Jan 15;48(2):iv.
van Ingen J, et al.
Clinical Relevance of Mycobacterium szulgai in
the Netherlands. Clin Infect Dis 2008;46:1200-1205.
Authors
Carlos M. Perez-Velez,
M.D.,
Shannon H. Kasperbauer,
M.D., and
Michael D. Iseman, M.D.
First Edition (1998): Michael D. Iseman, M.D.
and Charles W. Atwood, Jr., M.D.
|
www.antimicrobe.org